投资者关系活动档案 万达信息股份有限公司 投资者关系活动 | --- | --- | |-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ...

Company Overview - The company's vision is to better connect people and services, aiming to become a link between the government and the market, focusing on the healthcare sector [1] - The company has established subsidiaries in Beijing, Nanjing, Sichuan, Ningbo, and Macau to deploy local operational services [2] Business Segmentation - Services are categorized into three main areas: individual households, enterprises, and government [2] - The company plans to expand its service offerings to include community and elderly care clouds, in addition to existing healthcare services [2] User Metrics - The Health Cloud has initiated a pilot program in Shanghai, currently serving 5.35 million users, with a portion being paid users [2] - The Medical Cloud has established a B2B drug procurement platform, with strategic partnerships formed with major pharmaceutical companies [2] - The Medical Insurance Cloud serves over 80 cities, impacting 150 million people [2] Future Directions - The company is focused on integrating basic medical insurance with commercial insurance, ensuring the safety of basic insurance fund management while promoting combined development [3] - The company anticipates significant growth in user numbers through successful pilot programs and strategic partnerships, aiming to increase chronic disease management rates from 10% to 20% [5] Operational Strategy - The company has a competitive advantage through its regional health platforms and drug management systems, allowing for comprehensive healthcare services from management to payment [6] - Plans for employee growth are aligned with market demand, particularly in the healthcare service operations sector [8] Collaboration and Market Position - The company is exploring capital and business collaborations with commercial insurance firms, with expectations of announcements in 2016 [6] - The company does not engage in direct competition for appointment resources, focusing instead on comprehensive management platforms [7]

投资者关系活动档案 1 万达信息股份有限公司 投资者关系活动 | --- | --- | |-------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

Group 1: Company Overview - Wanda Information has focused on urban informationization for 23 years, becoming a leading company in China's smart city sector [2] - The company has achieved a CMMI Level 5 software capability, recognized as one of the first national-level integrated service enterprises [2] - Since its listing, Wanda Information has maintained a stable growth rate, with a compound annual growth rate (CAGR) of approximately 20% in revenue and over 22% in net profit over the past five years [2] Group 2: Financial Performance - In the first half of 2018, Wanda Information achieved a revenue of 1.01 billion yuan, a year-on-year increase of 15.89% [2] - The net profit attributable to shareholders was 77.2 million yuan, with a year-on-year growth of 101.63% [2] - The net profit after deducting non-recurring gains was 37.2 million yuan, reflecting a year-on-year increase of 17.19% [3] Group 3: Innovation and Business Expansion - Wanda Information's business encompasses eight major sectors, including health care, urban services, and financial insurance, leveraging cloud computing, big data, and AI technologies [3] - The company is expanding its strategic layout in health care, with a market share of No.1 among government clients, covering over 4,400 medical institutions nationwide [4] - The company has developed a comprehensive service system for health care, including real-time settlement and cross-regional medical insurance services [4] Group 4: Cloud Services and Technology - The company has over 2,000 institutions using its cloud HIS service, which is self-controlled, secure, and ready to use [4] - Wanda Information's cloud services are experiencing rapid growth, with a focus on creating unicorn businesses through industry collaboration [8] - The company has received the "Trusted Cloud Industry Cloud" award, indicating high security levels in its cloud services [7] Group 5: User Engagement and Market Reach - The Shanghai Citizen Cloud has registered 925,000 users, with over 1.5 million monthly active users, integrating services from over 30 government departments [7] - In Hainan, the Citizen Cloud has registered users exceeding 18% of the resident population, connecting 53 government departments [7] - The company plans to provide 100 government public services and collaborate with commercial institutions to offer 1,000 market-oriented services [7]

投资者关系活动档案 1 万达信息股份有限公司 投资者关系活动 | --- | --- | |-------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | | | 名称 | 万达信息股份有限公司 2018 年度三季报交流会 | | 时间 | 10 月 31 日（星期三）下午 15:30-17:30 | | 地点 | 上海市南京西路 1600 号 5 楼公司一号会议室 | | | | | | 董事长、总裁史一兵、财务总监卞世军、副总裁王兆进、总裁助理晏翥飞、董事 | | | 长助理蒋婷婷等 | | | | | | 爱建 ...

Company Overview - Wanda Information provides comprehensive solutions across multiple sectors, including healthcare, smart cities, and information technology [1] - The company is recognized as a key software enterprise in national planning and is the first in China to achieve CMMI5 certification [1][3] - It holds three top-level classified qualifications, with only 60 companies nationwide possessing such credentials [3] Technological Strength - Wanda Information has developed over 1,300 proprietary software products and holds 33 domestic and international patents [3] - The company has participated in over 50 national and industry standards related to information technology services and software engineering [3] Social Responsibility - During the COVID-19 pandemic, Wanda Information mobilized over 1,000 personnel to support epidemic prevention efforts, earning recognition as an excellent anti-epidemic enterprise by the Ministry of Industry and Information Technology [3] Strategic Partnership - Following a strategic investment from China Life, Wanda Information is implementing a 3+2 strategy, focusing on traditional strengths in smart healthcare and governance, while also developing innovative businesses in health management and smart cities [3][4] Health Management Business - The health management sector is a traditional strength, serving various public health institutions and healthcare agencies [5] - Wanda Information has developed a comprehensive health information platform covering 24 provinces, achieving the highest evaluation level [5][6] Market Position - The company has a significant market share in public health products and has deep involvement in the "Three Medical Linkage" reform, covering over 300 million people across 10 provinces [6][7] - Wanda Information's innovative DIP payment model has been adopted as a national standard for medical insurance reform, with trials in 71 cities [6][10] New Initiatives - The "Maniu Health" app aims to provide a one-stop health management service platform, targeting a wide range of users [8] - As of December 22, 2020, the app has accumulated over 1.65 million users, with significant growth in both active users and revenue [8] Future Development - The company plans to enhance its health management services through a phased approach, including establishing a health care team and integrating AI technologies [9] - Future phases will focus on chronic disease management and deep integration with China Life's health insurance offerings [9] Financial Insights - The health insurance market in China is projected to grow from 700 billion to 2 trillion yuan during the 14th Five-Year Plan period, with China Life expected to contribute significantly to this growth [7][10] - Wanda Information's strategic initiatives are designed to leverage this market potential, enhancing its competitive edge in the healthcare sector [10]

Financial Performance - The company's revenue for Q3 2022 was ¥1,097,299,872.57, representing a 41.38% increase compared to the same period last year[6]. - The net profit attributable to shareholders was -¥99,814,488.30, a decrease of 1,088.84% year-on-year[6]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥102,160,521.03, down 1,471.78% compared to the previous year[6]. - Total operating revenue for the current period is ¥2,229,637,822.98, a decrease of 11.8% compared to ¥2,528,751,234.23 in the previous period[31]. - Net profit for the current period is -¥342,227,349.06, compared to a net profit of ¥16,123,481.21 in the previous period, indicating a significant decline[34]. - Operating profit for the current period is -¥315,201,920.22, a drop from ¥21,410,024.65 in the previous period[34]. - The company reported a total comprehensive income of -¥342,235,949.80, compared to ¥16,107,786.02 in the previous period[34]. - Basic earnings per share for the current period is -0.2703, down from 0.031 in the previous period[34]. Assets and Liabilities - The total assets at the end of the reporting period were ¥6,799,477,343.42, a decrease of 4.83% from the end of the previous year[6]. - The equity attributable to shareholders decreased by 20.61% to ¥1,234,081,363.82 compared to the end of the previous year[6]. - The company's current assets totaled CNY 3,773,806,395.03, down from CNY 3,936,806,927.31 at the start of the year[24]. - The total liabilities of the company were CNY 5,603,209,248.54, slightly down from CNY 5,606,181,965.95[27]. - The total equity attributable to shareholders of the parent company decreased to CNY 1,234,081,363.82 from CNY 1,554,426,979.42, reflecting a decline of about 20.6%[30]. - The total non-current liabilities amounted to CNY 597,652,081.48, an increase from CNY 425,804,774.08[27]. Cash Flow - Cash flow from operating activities was -¥857,904,097.65, showing an increase of 8.58% year-on-year[6]. - The net cash flow from operating activities was -857,904,097.65, an improvement from -938,461,386.92 in the previous period, indicating a reduction in cash outflow[37]. - Total cash inflow from financing activities was 2,569,030,600.00, down from 3,055,147,200.00 in the previous period[37]. - The net cash flow from financing activities increased to 547,494,725.52 from 394,799,852.30 in the previous period, showing improved financing efficiency[40]. - Cash and cash equivalents at the end of the period were 827,510,226.77, up from 711,964,638.76 in the previous period[40]. - The total cash outflow from operating activities was 2,866,732,026.02, compared to 2,701,871,968.54 in the previous period, reflecting increased operational expenditures[37]. Expenses and Taxation - The company reported a 100.78% increase in taxes and surcharges compared to the same period last year[15]. - Tax expenses for the current period amounted to ¥25,717,859.79, compared to ¥5,235,183.35 in the previous period, indicating a significant increase[34]. - The company paid 129,745,104.44 in taxes, significantly higher than 54,631,744.90 in the previous period, indicating increased tax liabilities[37]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 43,339[17]. - The company's undistributed profits as of September 30, 2022, were CNY -2,292,458,724.63, compared to CNY -1,972,121,709.77 at the beginning of the year[30].

Financial Performance - The company's operating revenue for the first half of 2022 was ¥1,132,337,950.41, a decrease of 35.39% compared to ¥1,752,615,881.73 in the same period last year[29]. - The net profit attributable to shareholders of the listed company was -¥220,522,526.56, representing a decline of 926.18% from ¥26,691,746.56 in the previous year[29]. - The net cash flow from operating activities was -¥963,340,418.89, which is a 16.07% increase in cash outflow compared to -¥829,984,314.10 in the same period last year[29]. - The total assets at the end of the reporting period were ¥6,897,593,680.51, down 3.46% from ¥7,144,767,492.31 at the end of the previous year[29]. - The net assets attributable to shareholders of the listed company decreased by 14.20% to ¥1,333,662,011.88 from ¥1,554,426,979.42 at the end of the previous year[29]. - The basic earnings per share for the reporting period was -¥0.1861, a decrease of 927.11% compared to ¥0.0225 in the same period last year[29]. - The company reported a gross profit margin of 30.07%, down 4.59 percentage points year-on-year[109]. - The company reported a significant increase in inventory, reaching ¥1,299,903,533.78, which is 18.85% of total assets[118]. - Cash and cash equivalents decreased to ¥715,348,887.36, representing 10.37% of total assets, down 6.58% from the previous year[121]. - The company reported a net increase in cash and cash equivalents of -517 million yuan, an improvement of 17.99% compared to the previous year[113]. Business Operations and Strategy - The company has established a comprehensive product and solution portfolio in the smart healthcare sector, covering over 30 provinces and municipalities, serving more than 600 million people[40]. - In the first half of 2022, the company successfully expanded its smart healthcare business into new regions including Urumqi, Guangxi, and Sichuan, enhancing its market presence[41]. - The smart medical insurance sector has seen the company assist in the implementation and acceptance of national medical insurance platforms across multiple provinces, maintaining a leading market share[44]. - The company has been actively involved in the construction of regional medical centers, including a project for the Zhengzhou Children's Hospital, enhancing its technological foundation for regional healthcare[45]. - The company has deepened its digital transformation efforts, focusing on public health and smart healthcare solutions to meet evolving market demands[43]. - The company has expanded its government service projects in collaboration with major banks, enhancing trust and recognition in the market regulatory sector across 31 provinces[53]. - The company has participated in the national medical insurance payment reform, expanding its services to 15 cities and maintaining a leading position in the market[44]. - The company is actively exploring new market expansion models for smart city construction and operation, aiming for sustainable growth[73]. Research and Development - The company’s R&D investment was 132 million yuan, a decrease of 14.51% compared to the previous year[113]. - The company plans to increase R&D investment to maintain technological leadership and core competitiveness[164]. - The company has achieved significant advancements in information security services, with a team certified in various industry-standard security certifications[102]. - The company has accumulated over 2,500 independent intellectual property rights, with approximately 200 obtained during the reporting period[92]. - The company participated in over 50 national and industry standards related to information technology services and digital transformation[92]. Market and Product Development - The company has not disclosed any significant new product developments or market expansion strategies in the report[39]. - The company has received two design patents and was recognized in the InsurStar insurance technology industry list for its innovative healthcare solutions[84]. - The company’s smart healthcare solutions have led to significant advancements in medical insurance payment reforms and health information platforms[107]. - The company has established a strong presence in the smart healthcare sector, covering over 1,000 districts and counties across 26 provinces, with a market share exceeding 30% in Zhejiang Province[88]. - The "One Network for All Services" model, initiated by the company in Shanghai, has become a nationally promoted integrated government service model[89]. Financial Management and Investments - The company has not reported any issues or other situations regarding the use and disclosure of raised funds[140]. - The total amount of raised funds utilized during the reporting period was ¥4,017.99 million, with a cumulative total of ¥73,866.04 million[128]. - The company has not engaged in entrusted financial management, derivative investments, or entrusted loans during the reporting period[145][146][147]. - The company has not experienced any significant changes in project feasibility[137]. - The company has not reported any over-raised funds or their usage progress[137]. Challenges and Risks - The company is addressing risks related to industry competition, pandemic impacts, technology development, and talent retention[162][165][166][167]. - The company has faced delays in project progress due to the pandemic and the need for further development of accumulated results and experiences[132]. Corporate Governance - The company did not distribute cash dividends or issue bonus shares for the half-year period[174]. - There were no changes in the company's board of directors, supervisors, or senior management during the reporting period[173]. - The half-year financial report has not been audited[189]. - The company has not undergone any bankruptcy reorganization during the reporting period[190]. - The company has no significant litigation or arbitration matters during the reporting period[191].

Financial Performance - The company's operating revenue for Q1 2022 was ¥816,698,365.88, a decrease of 1.89% compared to ¥832,465,882.20 in the same period last year[5]. - Net profit attributable to shareholders increased by 214.11% to ¥13,381,835.46 from ¥4,260,233.34 year-on-year[5]. - Basic and diluted earnings per share rose by 213.89% to ¥0.0113 from ¥0.0036 in the same period last year[5]. - Total operating revenue for the current period was CNY 816,698,365.88, a decrease of 1.1% from CNY 832,465,882.20 in the previous period[30]. - Net profit attributable to the parent company was CNY 13,381,835.46, significantly up from CNY 4,260,233.34 in the previous period, reflecting a growth of approximately 214%[33]. Cash Flow - The net cash flow from operating activities was -¥729,894,368.10, a decline of 6.34% compared to -¥686,353,710.69 in the previous year[5]. - The company reported a net cash inflow from operating activities of CNY 393,899,388.34, down from CNY 480,573,913.63 in the previous period, representing a decline of about 18%[37]. - The net cash flow from investing activities decreased by 264.87%, mainly due to increased capital expenditures and the absence of dividends from invested entities[14]. - The net cash flow from financing activities increased by 86.65%, driven by higher net inflows from bank loans[15]. - The net cash flow from investing activities was -12,579,955.86, compared to -3,447,757.81 in the previous period, showing increased cash outflow[40]. - Cash inflow from financing activities was 1,065,300,000.00, up from 952,847,200.00 in the previous period, indicating stronger financing efforts[40]. - The net cash flow from financing activities was 262,119,157.43, compared to 140,431,104.01 in the previous period, demonstrating improved financing performance[40]. Assets and Liabilities - Total assets at the end of the reporting period were ¥7,064,274,297.26, down 1.13% from ¥7,144,767,492.31 at the end of the previous year[5]. - Current liabilities totaled RMB 5,008,233,910.95, down from RMB 5,180,377,191.87, showing a decrease of about 3.3%[27]. - The total liabilities decreased to CNY 5,523,103,166.10 from CNY 5,606,181,965.95, showing a reduction of approximately 1.5%[30]. - Non-current liabilities increased to CNY 514,869,255.15 from CNY 425,804,774.08, marking an increase of about 20.9%[30]. - The company's total non-current assets decreased to RMB 3,127,726,176.60 from RMB 3,207,960,565.00, a decline of about 2.5%[27]. Expenses - The company reported a 47.67% increase in selling expenses, attributed to enhanced business development efforts and increased labor costs[10]. - Research and development expenses decreased by 30.56% due to the amortization of previously developed intangible assets[10]. - Research and development expenses for the current period were CNY 85,017,394.37, down from CNY 122,435,005.32 in the previous period, reflecting a decrease of approximately 30.6%[33]. - The cash outflow for purchasing goods and services was 491,210,570.56, down from 625,930,175.38 in the previous period, suggesting cost management efforts[40]. - The cash paid to employees was 543,700,907.38, slightly up from 533,416,623.38 in the previous period, reflecting stable labor costs[40]. - The cash paid for taxes increased to 55,494,686.51 from 16,969,831.94 in the previous period, indicating higher tax obligations[40]. Other Income and Comprehensive Income - Other income increased by 335.38%, primarily due to a rise in government subsidies received during the reporting period[13]. - Other comprehensive income attributable to the parent company was CNY -493,827.99, compared to CNY 87,696.42 in the previous period, indicating a negative shift[36]. Inventory and Receivables - Accounts receivable increased to RMB 733,113,945.67 from RMB 632,523,425.79, representing an increase of about 15.9%[24]. - Inventory rose to RMB 1,018,023,669.10, up from RMB 854,228,733.94, indicating an increase of approximately 19.2%[24]. - The company reported a significant increase in contract assets to RMB 1,028,251,608.22 from RMB 865,743,478.65, representing an increase of approximately 18.8%[24]. Cash and Cash Equivalents - The company's cash and cash equivalents decreased to RMB 730,388,362.45 from RMB 1,211,325,355.64 at the beginning of the year, reflecting a decline of approximately 39.6%[24]. - The total cash and cash equivalents at the end of the period were 724,726,950.38, down from 808,150,632.53 in the previous period, indicating a decrease in liquidity[43]. Market and Product Development - The company has not disclosed any new product developments or market expansion strategies in the provided data[29].

Financial Performance - The total operating revenue for 2021 was ¥3,513,114,014.44, representing a 16.78% increase compared to ¥3,008,271,072.45 in 2020[29]. - The net profit attributable to shareholders was ¥69,241,554.98, a significant recovery from a loss of ¥1,291,552,358.95 in 2020, marking a 105.36% improvement[29]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥8,513,147.22, compared to a loss of ¥1,368,100,090.08 in the previous year, reflecting a 100.62% increase[29]. - The basic earnings per share for 2021 was ¥0.06, a recovery from a loss of ¥1.10 per share in 2020, representing a 105.45% increase[29]. - The weighted average return on net assets was 4.62%, a significant improvement from -65.39% in 2020, indicating a 70.01% increase[29]. - The total assets at the end of 2021 amounted to ¥7,144,767,492.31, a 2.39% increase from ¥6,978,310,099.38 at the end of 2020[29]. - The net assets attributable to shareholders reached ¥1,554,426,979.42, up 6.17% from ¥1,464,130,102.92 in 2020[29]. - The gross profit margin improved to 33.49%, up by 17.64 percentage points year-on-year[151]. - The total signed contracts amounted to 17.3 billion yuan, a year-on-year increase of 7.4%, with a signed gross profit margin of 49%, up by 6 percentage points[144]. Cash Flow and Investment - The net cash flow from operating activities was ¥63,987,418.69, down 75.15% from ¥257,541,354.58 in 2020[29]. - The operating cash inflow for 2021 was CNY 3,664,189,610.56, representing a year-on-year increase of 5.56% compared to CNY 3,471,147,575.87 in 2020[183]. - The total cash outflow from investment activities surged by 144.87% to CNY 246,766,454.37 in 2021 from CNY 100,774,113.94 in 2020, leading to a net cash flow from investment activities of -CNY 217,520,810.44[187]. - The financing activities cash inflow increased by 16.82% to CNY 4,277,856,174.62 in 2021 from CNY 3,662,000,000.00 in 2020, resulting in a net cash flow from financing activities of CNY 1,218,275.20[187]. - The company's cash and cash equivalents decreased by 41.99% to -CNY 152,395,892.22 in 2021 from -CNY 262,718,915.67 in 2020[187]. Revenue Breakdown - Revenue from traditional sectors grew by 14.1% year-on-year, achieving a gross profit margin of approximately 31.9%, an increase of 16 percentage points[145]. - Innovative business revenue surged by 41.8% year-on-year, accounting for 11.7% of total business, with a gross profit margin of about 45.3%, up by 27 percentage points[145]. - Revenue from the smart healthcare sector was 1.57 billion yuan, representing 44.68% of total revenue, with a year-on-year growth of 5.42%[147]. - Revenue from the smart government sector reached 1.53 billion yuan, accounting for 43.59% of total revenue, with a year-on-year increase of 24.63%[147]. - Revenue from internet services grew by 41.76% year-on-year, totaling 410.88 million yuan, which is 11.70% of total revenue[147]. Research and Development - Research and development expenses decreased by 26.40% from ¥641,113,753.48 in 2020 to ¥471,832,564.80 in 2021[166]. - The company's R&D investment amounted to ¥448,219,038.79 in 2021, representing 12.76% of total revenue, a decrease from 15.75% in 2020[174]. - The number of R&D personnel decreased by 7.55% from 3,989 in 2020 to 3,688 in 2021, with a notable increase in the number of PhD holders from 3 to 7[174]. - The capitalized R&D expenses for the year were ¥196,105,417.18, which accounted for 43.75% of total R&D investment, significantly up from 12.41% in 2020[174]. - The company has accumulated over 2,300 independent intellectual property rights, with 370 obtained during the reporting period[125]. Market and Strategic Focus - The company is focusing on the smart healthcare industry, which is expected to grow steadily through digital transformation, aligning with the "14th Five-Year Plan" for digital economy development[45]. - The company aims to strengthen its market position in the smart government sector, leveraging the increasing demand for digital governance solutions[49]. - The company is actively participating in the digital governance initiatives, with a focus on integrated online government services, which have gained significant traction since 2018[50]. - The company is committed to becoming a comprehensive service provider in "Internet + public health services" through innovation-driven growth[68]. - The company is focusing on high-quality development and expanding its market presence in smart healthcare and smart government sectors[144]. Social Impact and Community Engagement - The company has actively participated in public health initiatives, supporting over 20 provinces in pandemic prevention and control efforts[76]. - The health management platform has served over 10 million people through its internet+ vaccination services, with a comprehensive traceable process for over 1,000 vaccinations[109]. - The "Trustworthy Living Circle" initiative has attracted over 30,000 organizations, including government agencies and businesses, distributing over 60 million yuan in coupons to more than 20 million people[105]. - The company launched various social welfare projects, including a comprehensive information management system for veterans and a national pension service system, which is now operational in all 32 provinces[87]. Technology and Innovation - The company’s AI technology has been widely applied in healthcare and public services, showcasing its strong capabilities in artificial intelligence[130]. - The "Digital Pathology Management Platform" won the second prize at the 2021 CHITEC "Intel Cup" Digital Healthcare Innovation Service Competition[131]. - The company’s cloud computing services have been recognized with the Shanghai Science and Technology Progress Award (third prize)[130]. - The company has established a strong innovation capability with multiple national-level innovation platforms and has integrated emerging technologies such as AI, big data, and cloud computing into its services[127]. - The company is developing the "Future City Smart Service Platform Project," which aims to integrate community governance and services using cloud computing, big data, IoT, and AI technologies[175].